Fig. 2.
Fig. 2. Comparison of the Gla-domains of plasma factor IX, wild-type factor IX, and factor IXR94S. (A) Increasing moles of factor IXpl (○), factor IXwt (•), or factor IXR94S (▴) were coated onto microtiter wells and then incubated with 15 μg/mL of IX/X-bp in the presence of 5 mmol/L Ca2+ in TBS. The binding of IX/X-bp to factor IX was measured by ELISA. The three factor IX proteins bound IX/X-bp equally well. (B) Binding of factor IX to 75:25 DOPC:DOPS vesicles. The three factor IX proteins bound phospholipid vesicles equally well. The bars and errors represent the mean and standard deviation (SD) of three experiments.

Comparison of the Gla-domains of plasma factor IX, wild-type factor IX, and factor IXR94S. (A) Increasing moles of factor IXpl (○), factor IXwt (•), or factor IXR94S (▴) were coated onto microtiter wells and then incubated with 15 μg/mL of IX/X-bp in the presence of 5 mmol/L Ca2+ in TBS. The binding of IX/X-bp to factor IX was measured by ELISA. The three factor IX proteins bound IX/X-bp equally well. (B) Binding of factor IX to 75:25 DOPC:DOPS vesicles. The three factor IX proteins bound phospholipid vesicles equally well. The bars and errors represent the mean and standard deviation (SD) of three experiments.

Close Modal

or Create an Account

Close Modal
Close Modal